Psychopharmacology explores the use of medications to treat mental health disorders. From antidepressants to antipsychotics, understanding the mechanisms, efficacy, and side effects of these drugs is crucial. The Journal of Clinical Psychiatry offers in-depth insights into psychopharmacological treatments, their applications, and the latest research. Our expert editors curate content that is evidence-based and clinically relevant, ensuring psychiatrists are well-informed about the latest developments in medication-based treatments.
Psychopharmacology
Recently published article about Psychopharmacology
The Psychological Burden of ALS, the Enduring Strength of People Living With ALS, and the Tools We Can Use to Help
December 13, 2023
Commenting on a recent article by Lester et al, the authors discuss the psychological impacts of diagnosis, genetic testing, and disease progression on patients with amyotrophic lateral sclerosis (ALS).
Recent JCP Articles on Psychopharmacology
ChEIs for Delusions and Hallucinations in Alzheimer Disease and Parkinson Disease: Significant Benefits?
July 31, 2023
Chittaranjan Andrade, MD, takes a closer look at a recent meta-analysis indicating that donepezil, rivastigmine, and galantamine lessened both delusions and hallucinations in Alzheimer disease and Parkinson disease.
Recent PCC Articles on Psychopharmacology
Drug-Related Problems Following Use of Clonazepam Oral Drops
September 23, 2021
Drug-related problems associated with clonazepam oral drops have been reported to local postmarketing surveillance services recently. Here, the authors present an investigation to determine if such events were associated...
Featured Psychopharmacology Research
Control Conditions in Randomized Trials of Psychedelics: An ACTTION Systematic Review
May 10, 2023
Randomized trials of psychedelics underutilize blind assessment, active drug controls, and testing psychological support against minimal-support conditions—elements that would improve quality or provide important information.